This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Escherichia coli is a probiotic indicated to treat urinary tract infections and irritable bowel syndrome.
- Generic Name
- Escherichia coli
- DrugBank Accession Number
- DB16539
- Background
Not Available
- Type
- Biotech
- Groups
- Experimental
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 514B9K0L10
- CAS number
- 68583-22-2
References
- General References
- External Links
- 350202
- Wikipedia
- Escherichia_coli
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Prevention Cervical Cancer / Cervical Intraepithelial Neoplasia (CIN) / Persistent Infection / Vaginal Intraepithelial Neoplasia / Vulvar Intraepithelial Neoplasia (VIN) 1 4 Completed Prevention Hepatitis E 4 4 Completed Treatment Endotoxin, Escherichia Coli / Regional Blood Flow / Retina 1 3 Active Not Recruiting Prevention Human Papillomavirus (HPV) Infections 2 2 Completed Not Available Diarrhea 1 2 Completed Prevention Human Papillomavirus (HPV) Infections 1 2 Completed Prevention Influenza Infection 1 2 Recruiting Diagnostic Alcohol Use Disorders (AUD) / Craving / Depressed mood / Inflammatory Responses 1 2 Terminated Prevention Bacillus Anthracis (Anthrax) 1 2, 3 Completed Other Fibromyalgia 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Solution / drops Oral Capsule Oral 6 mg - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at February 02, 2021 22:27 / Updated at May 05, 2021 20:32